STOCK TITAN
  1. Home
  2. Sec-filings
  3. ANGO
  4. [SCHEDULE 13G] AngioDynamics, Inc. SEC Filing

[SCHEDULE 13G] AngioDynamics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ANGO logo
Angiodynamics

NASDAQ:ANGO

ANGO Rankings

#4667 Ranked by Market Cap
N/A Ranked by Dividends

ANGO Latest News

Jul 15, 2025
AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth
Jul 7, 2025
AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025
Jun 23, 2025
AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F18⁸⁵ System for Treatment of Acute Pulmonary Embolism
Apr 2, 2025
AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results
Mar 31, 2025
AngioDynamics to Host Virtual Cardiovascular Investor Event

ANGO Latest SEC Filings

Jul 18, 2025
[Form 4] AngioDynamics, Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] AngioDynamics, Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] AngioDynamics, Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] AngioDynamics, Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] AngioDynamics, Inc. Insider Trading Activity

ANGO Stock Data

384.95M
37.98M
5.62%
84.63%
4.24%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LATHAM